Skip to main content
. 2019 Apr 16;19:100. doi: 10.1186/s12935-019-0822-1

Fig. 4.

Fig. 4

Expression and survival analysis in subgroups. a Expression pattern of the gene signature in different AJCC-TNM stages. b Signature-based risk score is a promising marker for overall survival in subgroups with different tumour stages and EGFR and KRAS statuses